SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
THEMED DISCUSSION MODERATOR
Gerardo Garcia-Lerma
Centers for Disease Control and Prevention, Atlanta , GA, USA
LOW PREVALENCE OF INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE ACROSS BOTSWANA (ABSTRACT
542)
Simani Gaseitsiwe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
HIGH LEVEL RESISTANCE TO DOLUTEGRAVIR (DTG) AFTER EMERGENCE OF T97A MUTATION (ABSTRACT
543)
Safia S Kuriakose
Leidos Biomedical Research, Inc, Bethesda, MD, USA
UNINTEGRATED VIRAL DNA INVOLVED IN DOLUTEGRAVIR RESISTANCE (ABSTRACT
544)
Olivier Delelis
École Normale Supérieure de Cachan, Cachan, France
PREVALENCE AND CLINICAL IMPACT OF MINORITY RESISTANT VARIANTS TO INTEGRASE INHIBITORS (ABSTRACT
545)
Thuy Thi Thu Nguyen
Hôpital Pitié-Salpêtrière, Laboratoire de Virologie, PARIS, France
INTEGRASE INHIBITOR RESISTANCE SELECTIONS INITIATED WITH DRUG RESISTANT HIV-1 (ABSTRACT
546)
Kristen Andreatta
Gilead Sciences, Foster City, CA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
